Vanderbilt Health Will Appoint New Pharmacy Medical Director
Kevin Byram will lead the specialty pharmacy operations starting in October.
Updated on Sept. 24, 2026 in People
Vanderbilt Health announced that Kevin Byram will serve as the new medical director for its specialty pharmacy, effective October 1, 2026. He will succeed Sara Horst in the leadership role.
Why it matters
The appointment transitions leadership for a specialized department focused on complex disease management and patient therapy support. This shift maintains the operational continuity of a facility recognized for rare disease treatment expertise.
The specialty pharmacy is staffed by more than 70 pharmacists and pharmacy technicians. The facility has been in operation since its 2011 launch.
The players
Kevin Byram
He is an associate professor of medicine in the division of rheumatology and immunology who currently leads rheumatology at The Vanderbilt Clinic.
Sara Horst
She is transitioning from her role as pharmacy medical director to become the vice chair for clinical informatics and care transformation.
Vanderbilt Health
This Nashville-based healthcare provider operates an accredited rare disease pharmacy center of excellence.
The details
Kevin Byram, currently the medical director of rheumatology at The Vanderbilt Clinic, will oversee specialty therapy management programs and financial counseling. He concurrently serves as an associate professor of medicine and co-director of the Vanderbilt Vasculitis Center.
Timeline
The specialty pharmacy launched in 2011.
The appointment news release was published on Sept. 24, 2026.
Kevin Byram begins his new role on Oct. 1, 2026.
Market Landscape
This leadership transition occurs within a highly specialized sector of the healthcare market. It reinforces the institution's commitment to maintaining its accredited status as a rare disease pharmacy center of excellence.
Patients utilizing the specialty pharmacy can expect continuity in therapy management and financial counseling services. The transition to new leadership is designed to maintain existing patient care standards.
The takeaway
Professional leadership transitions at specialty pharmacies ensure that advanced therapy programs remain consistent for patients with rare conditions. Patients should maintain their current care routines without interruption as the new director takes office.
Further reading
Learn more about the latest leadership developments in the Nashville People section.
Source note: This article includes information reported by Becker's Hospital Review | Healthcare News & Analysis.
